Deep Track Capital
Overview
Deep Track Capital is a Greenwich, Connecticut-based investment firm founded in 2020 that focuses exclusively on the life sciences industry. The firm invests in both public and pre-IPO biotechnology companies, developing long-term partnerships with management teams. Its investment strategy includes leading transactions, building large syndicates, and investing in rounds led by other investors. The firm's primary focus is on biotechnology, pharmaceuticals, medical devices, diagnostics, and life sciences companies. Deep Track Capital is registered with the SEC as an investment adviser.
Portfolio Companies
44
Website
deeptrackcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Estuary Biotherapeutics | Oct 2026 | Series A | Co-investor |
| Superluminal Medicines | Sep 2026 | Series B | Co-investor |
| Draig Therapeutics | Jul 2026 | Series B | Lead |
| ARCYN Defense | Jul 2026 | Seed | Co-investor |
| Oblenio Bio | Jun 2026 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Deep Track Capital based?
Deep Track Capital is headquartered in Greenwich, Connecticut, United States.
When was Deep Track Capital founded?
Founding year information for Deep Track Capital is not publicly available.
How many portfolio companies does Deep Track Capital have?
Deep Track Capital has 44 portfolio companies in Caplight's dataset.
What are some companies in Deep Track Capital's portfolio?
Recent investments visible on Caplight include Estuary Biotherapeutics, Superluminal Medicines, Draig Therapeutics, ARCYN Defense, Oblenio Bio.
What was Deep Track Capital's most recent investment?
Deep Track Capital's most recent investment on Caplight was in Estuary Biotherapeutics in 2026.
What sectors does Deep Track Capital focus on?
Deep Track Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Deep Track Capital focus on?
Deep Track Capital typically invests at the Mid stage.
What is Deep Track Capital's AUM?
Deep Track Capital's assets under management are estimated between $5.1B and $5.2B.